Sinnberg T - Search Results

1

Genomics of Immunotherapy-Associated Hyperprogressors-Letter.

Forschner A, Niessner H, Möller Y, Horak P, Fröhlich M, Warsow G, Stenzinger A, Fröhling S, Glimm H, Klumpp B, Garbe C, Sinnberg T. Forschner A, et al. Among authors: sinnberg t. Clin Cancer Res. 2017 Oct 15;23(20):6374-6375. doi: 10.1158/1078-0432.CCR-17-1480. Clin Cancer Res. 2017. PMID: 29030332 No abstract available.

2

Effective Targeting of Melanoma Cells by Combination of Mcl-1 and Bcl-2/Bcl-x_L/Bcl-w Inhibitors.

Peng Z, Gillissen B, Richter A, Sinnberg T, Schlaak MS, Eberle J. Peng Z, et al. Among authors: sinnberg t. Int J Mol Sci. 2024 Mar 19;25(6):3453. doi: 10.3390/ijms25063453. Int J Mol Sci. 2024. PMID: 38542429 Free PMC article.

3

Sensitivity of Cutaneous T-Cell Lymphoma Cells to the Mcl-1 Inhibitor S63845 Correlates with the Lack of Bcl-w Expression.

Sumarni U, Zhu J, Sinnberg T, Eberle J. Sumarni U, et al. Among authors: sinnberg t. Int J Mol Sci. 2022 Oct 18;23(20):12471. doi: 10.3390/ijms232012471. Int J Mol Sci. 2022. PMID: 36293331 Free PMC article.

4

Skin Cancer Induction by the Antimycotic Drug Voriconazole Is Caused by Impaired DNA Damage Detection Due to Chromatin Compaction.

Giovannini S, Weibel L, Schittek B, Sinnberg T, Schaller M, Lemberg C, Fehrenbacher B, Biesemeier A, Nordin R, Ivanova I, Kurz B, Svilenska T, Berger C, Bourquin JP, Kulik A, Fassihi H, Lehmann A, Sarkany R, Kobert N, van Toorn M, Marteijn JA, French LE, Rocken M, Vermeulen W, Kamenisch Y, Berneburg M. Giovannini S, et al. Among authors: sinnberg t. J Invest Dermatol. 2024 Nov;144(11):2465-2476. doi: 10.1016/j.jid.2024.03.050. Epub 2024 Jul 22. J Invest Dermatol. 2024. PMID: 39047967

5

Putative Cancer Stem Cell Markers are Frequently Expressed by Melanoma Cells in Vitro and in Situ but are also Present in Benign Differentiated Cells.

Speigl L, Janssen N, Weide B, Sinnberg T, Pawelec G, Shipp C. Speigl L, et al. Among authors: sinnberg t. Front Biosci (Landmark Ed). 2023 Sep 6;28(9):193. doi: 10.31083/j.fbl2809193. Front Biosci (Landmark Ed). 2023. PMID: 37796710 Free article.

6

Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade.

Wyss N, Berner F, Walter V, Jochum AK, Purde MT, Abdou MT, Sinnberg T, Hofmeister K, Pop OT, Hasan Ali O, Bauer J, Cheng HW, Lütge M, Klümper N, Diem S, Kosaloglu-Yalcin Z, Zhang Y, Sellmer L, Macek B, Karbach J, König D, Läubli H, Zender L, Meyer BS, Driessen C, Schürch CM, Jochum W, Amaral T, Heinzerling L, Cozzio A, Hegazy AN, Schneider T, Brutsche MH, Sette A, Lenz TL, Walz J, Rammensee HG, Früh M, Jäger E, Becher B, Tufman A, Nuñez N, Joerger M, Flatz L. Wyss N, et al. Among authors: sinnberg t. Am J Respir Crit Care Med. 2024 Oct 1;210(7):919-930. doi: 10.1164/rccm.202311-2136OC. Am J Respir Crit Care Med. 2024. PMID: 38626354

7

Enhanced Apoptosis and Loss of Cell Viability in Melanoma Cells by Combined Inhibition of ERK and Mcl-1 Is Related to Loss of Mitochondrial Membrane Potential, Caspase Activation and Upregulation of Proapoptotic Bcl-2 Proteins.

Peng Z, Gillissen B, Richter A, Sinnberg T, Schlaak MS, Eberle J. Peng Z, et al. Among authors: sinnberg t. Int J Mol Sci. 2023 Mar 4;24(5):4961. doi: 10.3390/ijms24054961. Int J Mol Sci. 2023. PMID: 36902392 Free PMC article.

8

[Melanoma-associated macrophages-from molecular signals to therapeutic application].

Chatziioannou E, Aydin SA, Forchhammer S, Sinnberg T, Eigentler T. Chatziioannou E, et al. Among authors: sinnberg t. Dermatologie (Heidelb). 2022 Dec;73(12):915-928. doi: 10.1007/s00105-022-05077-3. Epub 2022 Nov 17. Dermatologie (Heidelb). 2022. PMID: 36394590 Review. German.

9

Combined inhibition of MAPK and mTOR signaling inhibits growth, induces cell death, and abrogates invasive growth of melanoma cells.

Lasithiotakis KG, Sinnberg TW, Schittek B, Flaherty KT, Kulms D, Maczey E, Garbe C, Meier FE. Lasithiotakis KG, et al. Among authors: sinnberg tw. J Invest Dermatol. 2008 Aug;128(8):2013-23. doi: 10.1038/jid.2008.44. Epub 2008 Mar 6. J Invest Dermatol. 2008. PMID: 18323781 Free article.

10

Inhibition of PI3K-AKT-mTOR signaling sensitizes melanoma cells to cisplatin and temozolomide.

Sinnberg T, Lasithiotakis K, Niessner H, Schittek B, Flaherty KT, Kulms D, Maczey E, Campos M, Gogel J, Garbe C, Meier F. Sinnberg T, et al. J Invest Dermatol. 2009 Jun;129(6):1500-15. doi: 10.1038/jid.2008.379. Epub 2008 Dec 11. J Invest Dermatol. 2009. PMID: 19078992 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters